Iran and Tajikistan ministers strengthen health cooperation
The ministers of health from Iran and Tajikistan convened on March 5 in Tehran. The meeting took place on the sidelines of the inaugural international conference on family health, ASIA-Plus reported.
Iranian Health Minister Bahram Einollahi and Tajik Minister of Health and Social Protection of the Population Jamoliddin Abdullozoda engaged in discussions aimed at fostering mutual cooperation in various facets of healthcare. Einollahi, expressing optimism about the prospects of collaboration, emphasized the importance of establishing a joint working group dedicated to advancing bilateral relations, not only in health but also in other domains.
The Iranian minister underscored the potential benefits of initiatives such as student and faculty exchanges, scientific conferences, and collaborative research projects in bolstering cooperation between the two countries. Einollahi further extended Iran's readiness to support Tajikistan by offering to export medical equipment, jointly manufacture pharmaceuticals, and facilitate the exchange of medical expertise.
Abdullozoda, in response, commended Iran's initiative in hosting the international medical conference and acknowledged the country's remarkable achievements in the field of healthcare. He lauded Iran's medical industry as successful and expressed a keen interest in fostering cooperation to develop joint pharmaceutical products.
The meeting between the two ministers took place amidst Tehran hosting the first international conference on family health, which saw participation from health ministers representing 20 nations. The conference, held on March 5-6, aimed to address strategies for transforming Primary Health Care into Universal Health Coverage, a crucial aspect of healthcare provision globally.
The discussions between Iran and Tajikistan signify a shared commitment to strengthening collaboration in healthcare, leveraging each other's strengths and resources for the benefit of their populations. By exploring avenues for joint ventures in pharmaceutical manufacturing, exchanging medical experiences, and facilitating technological transfer, both nations aim to elevate the quality and accessibility of healthcare services for their citizens.
Comments (0)